Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) Yvan Beaussant, Etienne Daguindau, Aurore Pugin, Mohamad Mohty, Hervé Avet-Loiseau, Damien Roos-Weil, Mauricette Michallet, Patrice Chevalier, Nicole Raus, Jean El-Cheikh, Reza Tabrizi, Anne Huyn, Agnès Buzyn, Gérard Socié, Laure Vincent, François Guilhot, Ibrahim Yakoub-Agha, Pascal Lenain, Sylvie François, Florence Beckerich, Bruno Lioure, Claude-Eric Bulabois, Eric Deconinck Biology of Blood and Marrow Transplantation Volume 21, Issue 8, Pages 1452-1459 (August 2015) DOI: 10.1016/j.bbmt.2015.04.020 Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 OS, PFS, and NRM in 448 allografts for myeloma patients with reduced-intensity (RIC, continuous line) or myeloablative conditioning (MAC, dotted line) regimens. Biology of Blood and Marrow Transplantation 2015 21, 1452-1459DOI: (10.1016/j.bbmt.2015.04.020) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Biology of Blood and Marrow Transplantation 2015 21, 1452-1459DOI: (10 Biology of Blood and Marrow Transplantation 2015 21, 1452-1459DOI: (10.1016/j.bbmt.2015.04.020) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions